Team:UIUC Illinois/Project/Parts

From 2013.igem.org

(Difference between revisions)
 
(22 intermediate revisions not shown)
Line 9: Line 9:
<script>
<script>
   $(function() {
   $(function() {
-
     $( "#accordion" ).accordion({ active: 1 });
+
     $( "#accordion" ).accordion({ active: 2 });
     $( "#accordion" ).accordion({
     $( "#accordion" ).accordion({
       collapsible: true
       collapsible: true
Line 26: Line 26:
<div id="igem"><a href="https://2013.igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/2013/0/08/IGEM_Logo.png" width="141.467" height="114.8" alt="iGEM" class="right" /></a> </div>  
<div id="igem"><a href="https://2013.igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/2013/0/08/IGEM_Logo.png" width="141.467" height="114.8" alt="iGEM" class="right" /></a> </div>  
<div id="accordion">
<div id="accordion">
 +
  <h3>Home</h3>
 +
  <ul>
 +
      <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois">Home</a></li>
 +
      <li style="margin-bottom:20px;"><a href="https://2012.igem.org/Team:UIUC-Illinois">2012 Team</a></li>
 +
  </ul>
   <h3>About</h3>
   <h3>About</h3>
   <ul>
   <ul>
Line 36: Line 41:
   <ul>
   <ul>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois/Project/Overview">Overview</a></li>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois/Project/Overview">Overview</a></li>
-
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois/Project/Background_Info">Background Info</a></li>  
+
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois/Project/Background_Info">Background</a></li>  
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois/Project/Design">Design</a></li>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois/Project/Design">Design</a></li>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois/Project/Parts"><u>Parts</u></a></li>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois/Project/Parts"><u>Parts</u></a></li>
Line 42: Line 47:
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:_UIUC_Illinois/Notebook">Notebook</a></li>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:_UIUC_Illinois/Notebook">Notebook</a></li>
   </ul>
   </ul>
-
   <h3>Medal Requirements</h3>
+
   <h3>Achievements</h3>
   <ul>
   <ul>
-
      <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team_UIUC_Illinois/Medal_Requirements">Requirements</a></li>
+
      <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team_UIUC_Illinois/Medal_Requirements">Achievements</a></li>
   </ul>
   </ul>
   <h3>Human Practices</h3>
   <h3>Human Practices</h3>
   <ul>
   <ul>
-
      <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team_UIUC_Illinois/Human_practices">Human Practices Main Page</a></li>
 
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois/Human_Practices/Outreach">Outreach</a></li>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois/Human_Practices/Outreach">Outreach</a></li>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois/Human_Practices/Ethics">Ethics</a></li>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:UIUC_Illinois/Human_Practices/Ethics">Ethics</a></li>
-
       <li style="margin-bottom:20px;"><a href="https://igem.org/Team:_UIUC_Illinos/Safety">Safety</a></li>
+
       <li style="margin-bottom:20px;"><a href="https://igem.org/Team:UIUC_Illinois/Safety/Main">Safety</a></li>
   </ul>
   </ul>
   <h3>Safety</h3>
   <h3>Safety</h3>
   <ul>
   <ul>
-
       <li style="margin-bottom:20px;"><a href="https://igem.org/Team:_UIUC_Illinos/Safety">Safety Main Page</a></li>
+
       <li style="margin-bottom:20px;"><a href="https://igem.org/Team:UIUC_Illinois/Safety/Main">Safety Main Page</a></li>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:_UIUC_Illinos/Safety/Forms">Safety Forms</a></li>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:_UIUC_Illinos/Safety/Forms">Safety Forms</a></li>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:_UIUC_Illinos/Safety/Database">EtBr Safety</a></li>
       <li style="margin-bottom:20px;"><a href="https://2013.igem.org/Team:_UIUC_Illinos/Safety/Database">EtBr Safety</a></li>
   </ul>
   </ul>
</div>
</div>
-
</a><a href="https://2013.igem.org/Team:UIUC_Illinois">Home Page</a>
 
   </div>
   </div>
-
 
<div id="container" class="left">   
<div id="container" class="left">   
     <div id="major_image">
     <div id="major_image">
-
     <img src="https://static.igem.org/mediawiki/2013/e/e8/Smiling_fox.jpg" width="720" height="294" alt="Smiling fox" />
+
     <img src="https://static.igem.org/mediawiki/2013/e/e1/UIUC_Plasmid_Maps%21%21%21.PNG" width="720" height="165" alt="plasmid maps" />
</div>
</div>
-
<p class="left">
+
<p class="center">
-
CARDIOBIOTICS PARTS: <br>
+
<b>Cardiobiotics Parts </b><br></p>
-
CDH <br>
+
<p class="left"> <b>Carnitine dehydrogenase (cdhCAB) BBa_K1205000 </b><br>
-
  - Derived from Pseudomonas Aeruginosa strain: PA01, this gene codes for Carnitine dehydrogenase that breaks down L-carnitine into 3-dehydrocarnitine. This enzyme directs the degradation down a pathway that prevents the formation of Trimethylamine. As previously mentioned Trimethylamine has been known to cause cardiovascular disease. This new pathway ultimately leads to glycine which is a nature substance in the body. This enzyme is the centerpiece of our experiment. <br>
+
  • Derived from <i>Pseudomonas aeruginosa PAO1</i>  <br>
 +
• This gene codes for L-Carnitine Dehydrogenase, a protein that breaks down L-carnitine into 3-Dehydrocarnitine. This enzyme directs the degradation down a pathway that prevents the formation of trimethylamine. As previously mentioned trimethylamine has been known to cause cardiovascular disease. This new pathway ultimately leads to glycine which is a nature substance in the body. This enzyme is the centerpiece of our experiment. <br>
Characterization: <br>
Characterization: <br>
-
  - This part was characterized with an enzymatic assay.  
+
  • This part was characterized with an enzymatic assay.  
 +
</p>
 +
<img style="-webkit-user-select: none" src="https://static.igem.org/mediawiki/2013/f/fd/UIUC_cdh_gelelec.jpg">
 +
<p>
   <br>
   <br>
   <br>
   <br>
-
CbcVW-
+
<b>cbcVW BBa_K1205002</b> <br>
-
-From Pseudomonas Aeruginosa PA01 <br>
+
• From <i>pseudomonas aeruginosa</i> strain PAO1 <br>
-
- Codes for a membrane bound protein that allows for the transport of L-carnitine into the cell.  <br>
+
• Codes for a membrane bound protein that allows for the transport of L-carnitine into the cell.  <br>
-
- This is crucial to our project because if we want to implement this as a system we need the cell to have the ability to uptake an excess of L-carnitine. <br>
+
• This is crucial to our project because if we want to implement this as a system we need the cell to have the ability to uptake an excess of L-carnitine. <br>
-
- Proof of functionality: LCMS Assay <br>
+
• Proof of functionality: LCMS Assay <br>
Characterization: <br>
Characterization: <br>
   Proof of functionality: LCMS <br>
   Proof of functionality: LCMS <br>
 +
</p>
 +
<img style="-webkit-user-select: none" src="https://static.igem.org/mediawiki/2013/3/3d/UIUC_cbcvw_gelelectro.jpg">
 +
<p>
<br>
<br>
-
CaiX <br>
+
<b>caiX BBa_K1205001</b> <br>  
-
-From Pseudomonas Aeruginosa PA01<br>
+
• From <i>pseudomonas aeruginosa</i> strain PAO1<br>
-
- Codes for a transport protein that allows for L-carnitine  to be directed to the membrane bound channel to then be transported into the cell. <br>
+
• Codes for a transport protein that allows for L-carnitine  to be directed to the membrane bound channel to then be transported into the cell. <br>
-
- This is crucial to our project because if we want to implement this as a system we need the cell to have the ability to uptake an excess of L-carnitine. <br>
+
• This is crucial to our project because if we want to implement this as a system we need the cell to have the ability to uptake an excess of L-carnitine. <br>
-
- Proof of functionality: LCMS Assay <br>
+
• Proof of functionality: LCMS Assay <br>
Characterization: <br>
Characterization: <br>
   Proof of functionality: LCMS <br>
   Proof of functionality: LCMS <br>
 +
</p>
 +
<img style="-webkit-user-select: none" src="https://static.igem.org/mediawiki/2013/2/2b/UIUC_caix_gelelect.jpg">
 +
<p>
 +
<br>
<br>
-
CbcX: <br>
+
<b>cbcX</b> <br>
-
-From Pseudomonas Aeruginosa PA01 <br>
+
• From <i>pseudomonas aeruginosa</i> strain PAO1 <br>
-
- Codes for a transport protien that takes Choline to a transport channel to increase rate of Choline uptake. <br>
+
• Codes for a transport protien that takes choline to a transport channel to increase rate of choline uptake. <br>
-
- This is useful to our project because Choline is also a compound that can be degraded to TMA. If we also modified its degredation our probiotic would be even more effective at decreases CVD. This gene would help increase uptake to maximize our probiotics effectiveness.<br> </p>
+
• This is useful to our project because choline is also a compound that can be degraded to TMA. If we also modified its degradation our probiotic would be even more effective in decreasing risk for CVD. This gene would help increase uptake to maximize our probiotic's effectiveness.<br>
 +
• Unfortunately, due to the constraints of time and money, this developed biobrick could not be characterized<br> </p>
</center>
</center>
</body>
</body>
</html>
</html>

Latest revision as of 03:47, 28 September 2013

Contact Us
UIUC iGEM
plasmid maps

Cardiobiotics Parts

Carnitine dehydrogenase (cdhCAB) BBa_K1205000
• Derived from Pseudomonas aeruginosa PAO1
• This gene codes for L-Carnitine Dehydrogenase, a protein that breaks down L-carnitine into 3-Dehydrocarnitine. This enzyme directs the degradation down a pathway that prevents the formation of trimethylamine. As previously mentioned trimethylamine has been known to cause cardiovascular disease. This new pathway ultimately leads to glycine which is a nature substance in the body. This enzyme is the centerpiece of our experiment.
Characterization:
• This part was characterized with an enzymatic assay.



cbcVW BBa_K1205002
• From pseudomonas aeruginosa strain PAO1
• Codes for a membrane bound protein that allows for the transport of L-carnitine into the cell.
• This is crucial to our project because if we want to implement this as a system we need the cell to have the ability to uptake an excess of L-carnitine.
• Proof of functionality: LCMS Assay
Characterization:
Proof of functionality: LCMS


caiX BBa_K1205001
• From pseudomonas aeruginosa strain PAO1
• Codes for a transport protein that allows for L-carnitine to be directed to the membrane bound channel to then be transported into the cell.
• This is crucial to our project because if we want to implement this as a system we need the cell to have the ability to uptake an excess of L-carnitine.
• Proof of functionality: LCMS Assay
Characterization:
Proof of functionality: LCMS


cbcX
• From pseudomonas aeruginosa strain PAO1
• Codes for a transport protien that takes choline to a transport channel to increase rate of choline uptake.
• This is useful to our project because choline is also a compound that can be degraded to TMA. If we also modified its degradation our probiotic would be even more effective in decreasing risk for CVD. This gene would help increase uptake to maximize our probiotic's effectiveness.
• Unfortunately, due to the constraints of time and money, this developed biobrick could not be characterized

Retrieved from "http://2013.igem.org/Team:UIUC_Illinois/Project/Parts"